UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 21, 2005
QUESTCOR PHARMACEUTICALS, INC.
California | 001-14758 | 33-0476164 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) | (I.R.S. Employer Identification No.) |
3260 Whipple Road Union City, California
|
94587 | |||
(Address of Principal Executive Offices)
|
(Zip Code) |
Registrants telephone number, including area code: (510) 400-0700
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) | ||||
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | ||||
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | ||||
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
On March 21, 2005, Questcor Pharmaceuticals, Inc. (the Company) appointed Barbara J. McKee as the Companys principal accounting officer. Ms. McKee, age 57, joined the Company in February 2005 as Director of Finance. She is responsible for the financial functions of the Company, including financial reporting, accounting and information systems. From September 1999 until joining the Company, Ms. McKee was a senior consultant with Macias & Ryan, Inc. providing business services, including interim infrastructure and financial project services, to biotechnology and emerging, high-growth companies, including the Company. Ms. McKee received her Bachelors degree in Business Administration from the University of Wisconsin in Madison, Wisconsin and her Masters degree in Management from Kellogg School of Management, Northwestern University, in Evanston, Illinois.
SIGNATURES
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: March 24, 2005 | QUESTCOR PHARMACEUTICALS, INC. |
|||
By: | /s/ JAMES L. FARES | |||
James L. Fares | ||||
President and Chief Executive Officer | ||||